The new "Vant" added to the Vivek Ramaswamy family, with its aim of improving trials with artificial intelligence, announced its new CEO this week.
Concept Life Sciences has taken two new lab spaces at Alderley Park, adding 55 scientists to sustain its 30% year-over-year growth momentum.
Looking to boost its drug offerings, U.K. CRO Clinigen has paid £150.3 million (around $200 million) to buy out Quantum Pharma.
A nonprofit CRO formed by several ex-DuPont scientists will start operating at a new lab on Oct.1.
Dutch virology CRO Viroclinics plans to expand its service offerings as it was acquired by private equity firm Parcom Capital.
Nonclinical service CRO Envigo is merging with publicly traded Avista Healthcare Public Acquisition Corporation.
Allscripts has partnered with Elligo Health Research to help physicians conduct clinical studies in their own clinics.
Parexel has joined forces with the Osaka International Cancer Institute to help “drive greater efficiencies” across trials in Japan.
Arcus inked an $816 million deal for a PD-1 drug developed by Chinese firms WuXi Biologics and Gloria Pharmaceuticals.
DNA-encoded library technology expert HitGen just inked a multiyear, multitarget drug discovery deal with Aduro Biotech.